journal
MENU ▼
Read by QxMD icon Read
search

OncoTargets and Therapy

journal
https://read.qxmd.com/read/30774387/znf433-positively-regulates-the-beta-catenin-tcf-pathway-in-prostate-cancer-and-enhances-the-tumorigenicity-of-cancer-cells
#1
Shuo Gu, Peijin Hou, Kun Liu, Xiaobing Niu, Bingjian Wei, Fei Mao, Zongyuan Xu
Background: Prostate cancer often shows the over-activation of beta-catenin/t-cell factor (TCF) signaling. It remains largely unknown how the beta-catenin/TCF transcriptional machinery is tightly controlled. Methods: The ZNF433 mRNA and protein levels in the clinical tissues were examined using q-PCR, Western blot and immunohistochemistry. The phenotypes of prostate cancer cells were examined using MTT assay, Boyden chamber assay and anchorage-independent assay...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774386/hifu-is-safe-effective-and-feasible-in-pancreatic-cancer-patients-a-monocentric-retrospective-study-among-523-patients
#2
Zhouyu Ning, Jing Xie, Qiwen Chen, Chenyue Zhang, Litao Xu, Libin Song, Zhiqiang Meng
Purpose: This study aimed to evaluate the clinical value of high-intensity focused ultrasound (HIFU) combined with gemcitabine (GEM) in treating unresectable pancreatic ductal adenocarcinoma (PDAC). Patients and methods: A total of 523 unresectable PDAC patients were recruited from December 30, 2007 to January 30, 2015 at Fudan University Shanghai Cancer Center. Among them, 347 received HIFU combined with GEM (with regional intra-arterial chemotherapy [RIAC] or with systemic chemotherapy) and the remaining patients received GEM only...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774385/downregulated-expression-of-rack1-results-in-pancreatic-cancer-growth-and-metastasis
#3
Lei Zhang, Yang Lv, Yefei Rong, Wenqi Chen, Yuan Fang, Weilin Mao, Wenhui Lou, Dayong Jin, Xuefeng Xu
Background: The expression and function of the Receptor for Activated C Kinase 1 (RACK1) in cancer growth and metastasis are confused in different cancers, especially in pancreatic ductal adenocarcinoma (PDAC). Methods: One-hundred and eighty-two PDAC tissue specimens (95 males and 87 females) including pancreatic cancer tissue and para-carcinoma tissue were collected for analysis between 2005 to 2012. Blood phenotypic parameters using cell count and capillary electrophoresis were investigated...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774384/hypertension-as-a-predictive-biomarker-in-patients-with-advanced-non-small-cell-lung-cancer-treated-with-apatinib
#4
Shen-Cun Fang, Wen Huang, Ying-Ming Zhang, Hai-Tao Zhang, Wei-Ping Xie
Background: Hypertension (HTN) is a common adverse event of the vascular endothelial growth factor pathway inhibitor apatinib. This study was conducted to evaluate the association of apatinib-induced HTN with clinical outcomes in patients with advanced non-small-cell lung cancer (NSCLC). Methods: We retrospectively analyzed 110 consecutive patients with advanced NSCLC who were treated with apatinib from August 2014 to January 2018. All patients were classified as normotensive or hypertensive based on blood pressure measurements after initiating therapy...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774383/mir-135a-suppresses-migration-of-gastric-cancer-cells-by-targeting-traf5-mediated-nf-%C3%AE%C2%BAb-activation
#5
Yongzheng Xie, Fangjun Li, Zheng Li, Zhaohui Shi
Background: As crucial regulators and possible biomarkers for cancer development, miRNAs have attracted intensive attention during the last two decades. Among the known miRNAs, miR-135a has been indicated as a tumor suppressor in several cancer types, whereas its roles and mechanisms in gastric cancer (GC) remain largely unclear. Materials and methods: Quantitative PCR (qPCR) was conducted to detect the expression of miR-135a in paired GC tissues as well as cell lines...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774382/efficacy-and-safety-of-targeted-therapy-for-metastatic-her2-positive-breast-cancer-in-the-first-line-treatment-a-bayesian-network-meta-analysis
#6
Fubin Feng, Tingting Zhang, Fang Yin, Cun Liu, Jing Zhuang, Lingyu Qi, Xue Wang, Jia Li, Lu Wang, Jinhui Tian, Changgang Sun
Purpose: Numerous HER2-targeted therapy clinical trials have demonstrated efficacy and safety in the first-line treatment of metastatic breast cancer (MBC). However, the direct or indirect comparison of these drugs is unclear. This network meta-analysis can solve this issue to some extent. Materials and methods: PubMed, Embase, and the Cochrane Library were searched for Phase II/III randomized controlled trials (RCTs) on metastatic HER2-positive breast cancer for first-line treatment up to December 16, 2017...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774381/the-coexistence-of-a-wilms-tumor-and-renal-cell-carcinoma-in-children-a-case-report-and-review-of-the-literature
#7
Xiao-Ping Zou, Yao-Ying Jiang, Yan Liao, Yi-Wu Dang, Gang Chen, Zhen-Bo Feng, Yun Ma
A combination of a Wilms' tumor (WT) and renal cell carcinoma (RCC) is an extremely rare pediatric renal neoplasm. Its prognosis and clinicopathological features remain unclarified. Herein, we describe a case of the coexistence of a WT and an RCC in a male child aged 5 years and 10 months. The child had symptoms of hematuria for more than 1 month. Although his irises were clear, medical imaging revealed a potential malignant tumor in the left kidney. The patient underwent resection of the left kidney. The pathological diagnosis was the coexistence of a WT and papillary RCC...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774380/the-expression-of-special-at-rich-binding-protein-1-in-cervical-cancer-and-its-clinical-significance
#8
Lijie Zhao, Yuhua Zheng, Yong Ji, Xiaoying Zhang
Background: The oncogenic potential of special AT-rich binding protein 1 (SATB1) has been reported in various types of cancer, but its function in cervical cancer remains not fully investigated. This study aimed to investigate the effect of SATB1 mRNA expression on tumor progression and outcomes in the cervical cancer patients. Methods: A total of 33 cervical cancer patients treated in our hospital from September 2012 to December 2015 were included. The mRNA expression level of STAB1 in cervical cancer tissue was determined by real-time PCR, and the patients were divided into dichotomous groups based on their SATB1 expression level...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774379/effects-of-combined-inhibition-of-stat3-and-vegfr2-pathways-on-the-radiosensitivity-of-non-small-cell-lung-cancer-cells
#9
Chenxi Hu, Wei Zhuang, Yun Qiao, Bin Liu, Liang Liu, Kaiyuan Hui, Xiaodong Jiang
Purpose: The goals of this study were to determine the effects of combined inhibition of STAT3 and vascular endothelial growth factor receptor 2 (VEGFR2) pathways on the radiosensitivity of non-small-cell lung cancer (NSCLC) cells, and to assess the underlying mechanisms. Methods: The expressions of VEGFR2, STAT3, related signaling molecules, hypoxia-inducible factor 1-alpha (HIF-1α), and cyclin D1 were determined by Western blotting. Radiosensitivity was assessed using the colony-forming assay, and cell cycle and cell death were analyzed by flow cytometry...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774378/establishing-a-detection-method-for-ccny-a-potentially-significant-clinical-investigative-marker-in-nsclc-patients
#10
Li Ma, Meng Gu, Yu Teng, Weiying Li
Background: CCNY, a novel cyclin family member, plays an increasingly important role in the progression of tumor invasion and metastasis, including lung cancer. However, the clinical significance of CCNY in non-small-cell lung cancer (NSCLC) patients is unknown. Patients and methods: We prepared CCNY monoclonal antibodies, validated specific peptides by a peptide array, and established a double-antibody sandwich ELISA detection method. Then, we measured CCNY levels in 100 NSCLC patients and 50 healthy controls...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774377/microrna-628-inhibits-the-proliferation-of-acute-myeloid-leukemia-cells-by-directly-targeting-igf-1r
#11
Lu Chen, Xin Jiang, Haoyue Chen, Qiaoyan Han, Chunhua Liu, Miao Sun
Background: A variety of microRNAs (miRNAs) are aberrantly expressed in acute myeloid leukemia (AML), and these dysregulated miRNAs perform crucial roles in tumorigenesis and progression of AML. miR-628-3p (miR-628), one of the miRNAs dysregulated in multiple types of human cancers, exerts antitumor roles in different cancer types. However, no specific study has explored the expression pattern and role of miR-628 in AML. Materials and methods: In this study, RT-qPCR was performed to detect miR-628 expression in AML tissues and cell lines...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774376/reversing-platinum-resistance-in-ovarian-cancer-multicellular-spheroids-by-targeting-bcl-2
#12
Ya'nan Yang, Song Li, Yiting Sun, Di Zhang, Zeyi Zhao, Lian Liu
Purpose: Peritoneal metastasis is the most common pathway for the spread of ovarian cancer. Ovarian cancer cells in ascites prefer to aggregate into the more chemoresistant multicellular spheroids (MCSs), leading to treatment failure and disease recurrence. We previously established a suspension MCS model of ovarian cancer cells in vitro and found that the MCS cells acquired drug resistance to cisplatin. In the present study, we aimed to uncover the underlying mechanism of the platinum resistance of MCS and the potential targets to reverse the drug resistance...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774375/cryptotanshinone-inhibits-esophageal-squamous-cell-carcinoma-in-vitro-and-in-vivo-through-the-suppression-of-stat3-activation
#13
Yubin Ji, Yichen Liu, Nina Xue, Tingting Du, Liyuan Wang, Rui Huang, Ling Li, Chunhong Yan, Xiaoguang Chen
Purpose: Esophageal squamous-cell carcinoma (ESCC) is the most common subtype of esophageal cancer, with a poor clinical outcome. Cryptotanshinone (CTS) is the main bioactive compound from the root of Salvia miltiorrhiza Bunge. Our study aimed to investigate the anti-cancer effects and molecular mechanisms of CTS on ESCC. Materials and methods: We investigated the anti-tumor activity of CTS on ESCC in vitro and in vivo. Activation of the STAT3 signaling pathway was evaluated in ESCC and HEK-Blue™ IL-6 cells...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774374/downregulation-of-cenpk-suppresses-hepatocellular-carcinoma-malignant-progression-through-regulating-yap1
#14
Jianlin Wang, Haimin Li, Congcong Xia, Xisheng Yang, Bin Dai, Kaishan Tao, Kefeng Dou
Background: Several studies have found that centromere protein K (CENPK) is overexpressed in several tumour types and promotes tumor progression. However, there has been little research on the role of CENPK in the progression of hepatocellular carcinoma (HCC). Materials and methods: The expression of CENPK in HCC tissues was quantified by Western blot and quantitative real-time PCR. Cells were transfected with lentiviral plasmids containing shRNA sequences targeting CENPK and YAP1 to silence the expression of CENPK and YAP1...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774373/efficacy-and-safety-of-nivolumab-for-metastatic-biliary-tract-cancer
#15
Miaomiao Gou, Yong Zhang, Haiyan Si, Guanghai Dai
Objective: PD-1 inhibitors have improved efficacy in many cancers. There are currently no reports of the use of PD-1 inhibitors, such as nivolumab, for metastatic biliary tract cancer (mBTC). This study reviewed the efficacy and safety of nivolumab for mBTC with the aim of exploring ways to improve efficacy and survival. Methods: Thirty patients with mBTC were voluntarily treated with nivolumab at the PLA General Hospital. Nivolumab 3 mg/kg was administered. Progression-free survival (PFS) and overall survival were evaluated by Kaplan-Meier and univariate and multivariate analyses were carried out for clinical characteristics...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774372/mir-206-inhibits-proliferation-migration-and-invasion-of-gastric-cancer-cells-by-targeting-the-muc1-gene
#16
Min Deng, Yiyu Qin, Xiaodong Chen, Qizhi Wang, Jianchao Wang
Background: MicroRNAs (miRNAs) can regulate the post-transcriptional level of gene expression. It has been documented that downregulation of miR-206 is significant in human gastric cancer (GC), whereas its role in GC cell biological behaviors, including proliferation, migration, and invasion, has not been thoroughly investigated. MiR-206 levels have a negative association with lymph node metastasis and tumor invasion, and patients with higher miR-206 expression have better prognoses. Functional studies demonstrated that miR-206 overexpression significantly suppresses GC cell proliferation, migration, and invasion, and induces apoptosis in vitro...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774371/mirna-101-5p-inhibits-the-growth-and-aggressiveness-of-nsclc-cells-through-targeting-cxcl6
#17
Qi Chen, Dan Liu, Zhi Hu, Cheng Luo, Si Lin Zheng
Background: The purpose of this study is to explore the potential biological roles of miR-101-5p in the progression of non-small-cell lung carcinoma (NSCLC). Methods: The levels of miR-101-5p and chemokine (C-X-C motif) ligand 6 (CXCL6) in NSCLC tissues and cells were detected using the quantitative real-time PCR (qRT-PCR) assay. Proliferation, colony formation, migration and invasion assays were conducted using miR-101-5p-transfected NSCLC cells in vitro. The expression of CXCL6 was measured using immunofluorescence assay...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774370/the-inhibitive-effect-of-sh-hif1a-as2-on-the-proliferation-invasion-and-pathological-damage-of-breast-cancer-via-targeting-mir-548c-3p-through-regulating-hif-1%C3%AE-vegf-pathway-in-vitro-and-vivo
#18
Xiao Guo, Shenghai Lee, Peilong Cao
Background: Breast cancer (BC) has been the commonest malignant tumor with a low survival rate among woman. Long non-coding RNA hypoxia-inducible factor-1 alpha antisense RNA-2 (HIF1A-AS2) was correlated with various cancers. Purpose: The study aimed to investigate the roles and related underlying molecular mechanisms of HIF1A-AS2 in BC. Material and methods: Target relationships were speculated by Targetscan 7.0 and confirmed by dual luciferase reporter assay...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774369/avasimibe-inhibits-tumor-growth-by-targeting-foxm1-akr1c1-in-osteosarcoma
#19
Liang Wang, Yang Liu, Guanzhen Yu
Background: Osteosarcoma (OS) is a rare bone tumor with a high propensity for lung metastasis and poor patient outcomes. It is crucial to identify novel therapeutic strategies and biomarkers. Patients and methods: ARK1C1 staining was detected in OS specimens, and its clinical significance was assessed. A potential AKR1C1 inhibitor, avasimibe, was used to target AKR1C1. Results: High expression of AKR1C1 was observed in OS and was associated with poor outcomes for patients with OS...
2019: OncoTargets and Therapy
https://read.qxmd.com/read/30774368/lncrna-small-nucleolar-rna-host-gene-20-predicts-poor-prognosis-in-glioma-and-promotes-cell-proliferation-by-silencing-p21
#20
Xiang-Sheng Li, Fa-Zheng Shen, Li-Yong Huang, Lei Hui, Rui-Hua Liu, Yan-Juan Ma, Bao-Zhe Jin
Background: In multiple cancers, long non-coding RNA small nucleolar RNA host gene 20 ( lncRNA SNHG20 ) is generally dysregulated. In the present study, both the biological role and clinicopathological value of lncRNA SNHG20 in glioma are explored. Methods: Real-time PCR was employed to determine lncRNA SNHG20 expression in glioma patients. The prognostic role of expression of lncRNA SNHG20 was evaluated in a retrospective cohort study. In addition, the association between lncRNA SNHG20 expression and the clinicopathological features of glioma patients, such as tumor recurrence, survival status, follow-up time, WHO grade, resection extent, tumor location, Karnofsky performance scale score, cystic change, tumor size, gender and age, was discussed...
2019: OncoTargets and Therapy
journal
journal
42549
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"